WallStSmart

EDAP TMS SA (EDAP)vsHenry Schein Inc (HSIC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Henry Schein Inc generates 20565% more annual revenue ($13.18B vs $63.80M). HSIC leads profitability with a 3.0% profit margin vs -30.8%. HSIC appears more attractively valued with a PEG of 1.60. HSIC earns a higher WallStSmart Score of 56/100 (C).

EDAP

Avoid

23

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 4.0Quality: 5.0

HSIC

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 5.5Value: 8.7Quality: 7.0
Piotroski: 5/9Altman Z: 2.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EDAP.

HSICUndervalued (+12.5%)

Margin of Safety

+12.5%

Fair Value

$93.39

Current Price

$74.25

$19.14 discount

UndervaluedFair: $93.39Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EDAP0 strengths · Avg: 0/10

No standout strengths identified

HSIC1 strengths · Avg: 8.0/10
Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Areas to Watch

EDAP4 concerns · Avg: 2.3/10
Market CapQuality
$134.99M3/10

Smaller company, higher risk/reward

PEG RatioValuation
90.472/10

Expensive relative to growth rate

Return on EquityProfitability
-59.5%2/10

ROE of -59.5% — below average capital efficiency

EPS GrowthGrowth
-62.2%2/10

Earnings declined 62.2%

HSIC3 concerns · Avg: 3.3/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

Profit MarginProfitability
3.0%3/10

3.0% margin — thin

Debt/EquityHealth
1.023/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : EDAP

EDAP has a balanced fundamental profile.

Bull Case : HSIC

The strongest argument for HSIC centers on Price/Book.

Bear Case : EDAP

The primary concerns for EDAP are Market Cap, PEG Ratio, Return on Equity.

Bear Case : HSIC

The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

EDAP profiles as a turnaround stock while HSIC is a value play — different risk/reward profiles.

HSIC carries more volatility with a beta of 0.85 — expect wider price swings.

HSIC is growing revenue faster at 7.7% — sustainability is the question.

HSIC generates stronger free cash flow (338M), providing more financial flexibility.

Bottom Line

HSIC scores higher overall (56/100 vs 23/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

EDAP TMS SA

HEALTHCARE · MEDICAL DISTRIBUTION · USA

EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France.

Henry Schein Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.

Visit Website →

Want to dig deeper into these stocks?